ArticleBlood advances2025

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.

Rudra Prasad Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.